Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Titan Pharmaceuticals Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- 0 vs. Q1 2022
- Shares held
- 665.4K
- −633.0K (−48.8%) vs. Q1 2022
- Total value
- $371.0K
- −$869.0K (−70.1%) vs. Q1 2022
- New holders
- 4
- 7 more added
- Sold out
- 4
- 1 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TTNP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $69 |
| Q1 2026 | 6 | $130 |
| Q4 2025 | 4 | $154 |
| Q3 2025 | 18 | $107.1K |
| Q2 2025 | 20 | $158.3K |
| Q1 2025 | 17 | $51.9K |
| Q4 2024 | 15 | $9.41K |
| Q3 2024 | 16 | $88.5K |
| Q2 2024 | 18 | $179.3K |
| Q1 2024 | 17 | $230.0K |
| Q4 2023 | 24 | $408.2K |
| Q3 2023 | 27 | $497.8K |
| Q2 2023 | 25 | $632.7K |
| Q1 2023 | 22 | $787.4K |
| Q4 2022 | 23 | $757.9K |
| Q3 2022 | 21 | $1.14M |
| Q2 2022 | 24 | $371.0K |
| Q1 2022 | 24 | $1.24M |
| Q4 2021 | 24 | $430.0K |
| Q3 2021 | 22 | $722.0K |
| Q2 2021 | 23 | $1.51M |
| Q1 2021 | 24 | $988.1K |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Titan Pharmaceuticals Inc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 240,710 | $135.0K | 0.00% | +204,200+559.3% | Added |
| Vanguard Group Inc | 74,895 | $42.0K | 0.00% | −131,533−63.7% | Reduced |
| Millennium Management LLC | 63,106 | $35.0K | 0.00% | +52,874+516.8% | Added |
| Virtu Financial LLC | 62,333 | $35.0K | 0.00% | +62,333 | New |
| Geode Capital Management, LLC | 62,353 | $34.0K | 0.00% | +9,300+17.5% | Added |
| Group One Trading, L.P. | 59,504 | $33.0K | 0.00% | +600+1.0% | Added |
| HRT Financial LP | 52,108 | $29.0K | 0.00% | +52,108 | New |
| UBS Group AG | 26,945 | $15.0K | 0.00% | +19,822+278.3% | Added |
| Ergoteles LLC | 18,978 | $11.0K | 0.00% | +18,978 | New |
| Level Financial Advisors, Inc. | 987 | $1.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,755 | $1.00K | 0.00% | +1,755 | New |
| American Portfolios Advisors | 23 | $13 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 206 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 81 | $0 | 0.00% | +13+19.1% | Added |
| FMR LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 16 | $0 | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 60 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 483 | $0 | 0.00% | +129+36.4% | Added |
| Westside Investment Management, Inc. | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 14 | $0 | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Joseph P. Lucia & Associates, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 2 | $0 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 844 | – | – | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −863,512−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −50,050−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −10,041−100.0% | Sold out |
| Fortitude Advisory Group L.L.C. | 0 | $0 | 0.00% | −8−100.0% | Sold out |